Perkinelmer, Inc. PKI
The next Perkinelmer, Inc. dividend will go ex in 5 days for 7c and will be paid in 27 days.
The previous Perkinelmer, Inc. dividend was 7c and it went ex 3 months ago and it was paid 2 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 14.4.
|Summary||Previous dividend||Next dividend|
|Declaration date||23 Jul 2020 (Thu)||22 Oct 2020 (Thu)|
|Ex-div date||15 Oct 2020 (Thu)||21 Jan 2021 (Thu)|
|Pay date||06 Nov 2020 (Fri)||12 Feb 2021 (Fri)|
Enter the number of Perkinelmer, Inc. shares you hold and we'll calculate your dividend payments:
Sign up for Perkinelmer, Inc. and we'll email you the dividend information when they declare.
Add Perkinelmer, Inc. to receive free notifications when they declare their dividends.
Your account is set up to receive Perkinelmer, Inc. notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Quarterly||16 Jan 2025||17 Apr 2025||09 May 2025||USD||Sign up||—|
|Forecast||Quarterly||17 Oct 2024||16 Jan 2025||07 Feb 2025||USD||Sign up||—|
|Forecast||Quarterly||18 Jul 2024||17 Oct 2024||08 Nov 2024||USD||Sign up||—|
|Forecast||Quarterly||25 Apr 2024||18 Jul 2024||09 Aug 2024||USD||Sign up||—|
|Forecast||Quarterly||18 Jan 2024||18 Apr 2024||10 May 2024||USD||Sign up||—|
|Forecast||Quarterly||19 Oct 2023||18 Jan 2024||09 Feb 2024||USD||Sign up||—|
|Forecast||Quarterly||20 Jul 2023||19 Oct 2023||10 Nov 2023||USD||Sign up||—|
|Forecast||Quarterly||27 Apr 2023||20 Jul 2023||11 Aug 2023||USD||Sign up||—|
|Forecast||Quarterly||19 Jan 2023||13 Apr 2023||10 May 2023||USD||Sign up||—|
|Forecast||Quarterly||20 Oct 2022||19 Jan 2023||10 Feb 2023||USD||Sign up||—|
|Forecast||Quarterly||21 Jul 2022||13 Oct 2022||04 Nov 2022||USD||Sign up||—|
|Forecast||Quarterly||28 Apr 2022||14 Jul 2022||05 Aug 2022||USD||Sign up||—|
|Forecast||Quarterly||20 Jan 2022||13 Apr 2022||10 May 2022||USD||Sign up||—|
|Forecast||Quarterly||21 Oct 2021||20 Jan 2022||11 Feb 2022||USD||Sign up||—|
|Forecast||Quarterly||22 Jul 2021||14 Oct 2021||05 Nov 2021||USD||Sign up||—|
|Forecast||Quarterly||29 Apr 2021||15 Jul 2021||06 Aug 2021||USD||Sign up||—|
|Forecast||Quarterly||21 Jan 2021||15 Apr 2021||10 May 2021||USD||Sign up||—|
|Declared||Quarterly||22 Oct 2020||21 Jan 2021||12 Feb 2021||USD||7c||7c||😄|
|Paid||Quarterly||23 Jul 2020||15 Oct 2020||06 Nov 2020||USD||7c||7c||😄|
|Paid||Quarterly||30 Apr 2020||16 Jul 2020||07 Aug 2020||USD||7c||7c||😄|
|Paid||Quarterly||23 Jan 2020||16 Apr 2020||08 May 2020||USD||7c||7c||😄|
|Paid||Quarterly||24 Oct 2019||16 Jan 2020||07 Feb 2020||USD||7c||7c||😄|
|Paid||Quarterly||25 Jul 2019||17 Oct 2019||08 Nov 2019||USD||—||7c|
|Paid||Quarterly||25 Apr 2019||18 Jul 2019||09 Aug 2019||USD||—||7c|
|Paid||Quarterly||24 Jan 2019||17 Apr 2019||10 May 2019||USD||—||7c|
|Paid||Quarterly||24 Oct 2018||17 Jan 2019||08 Feb 2019||USD||—||7c|
|Paid||Quarterly||23 Jul 2018||18 Oct 2018||09 Nov 2018||USD||—||7c|
|Paid||Quarterly||26 Apr 2018||19 Jul 2018||10 Aug 2018||USD||—||7c|
|Paid||Quarterly||25 Jan 2018||12 Apr 2018||10 May 2018||USD||—||7c|
|Paid||Quarterly||–||18 Jan 2018||09 Feb 2018||USD||—||7c|
|Paid||Quarterly||24 Jul 2017||19 Oct 2017||10 Nov 2017||USD||—||7c|
|Paid||Quarterly||28 Apr 2017||19 Jul 2017||10 Aug 2017||USD||—||7c|
|Paid||Quarterly||27 Jan 2017||11 Apr 2017||10 May 2017||USD||—||7c|
|Paid||Quarterly||26 Oct 2016||18 Jan 2017||10 Feb 2017||USD||—||7c|
|Paid||Quarterly||27 Jul 2016||12 Oct 2016||10 Nov 2016||USD||—||7c|
|Paid||Quarterly||25 Apr 2016||13 Jul 2016||10 Aug 2016||USD||—||7c|
|Paid||Quarterly||28 Jan 2016||13 Apr 2016||10 May 2016||USD||—||7c|
|Paid||Quarterly||29 Oct 2015||13 Jan 2016||10 Feb 2016||USD||—||7c|
|Paid||Quarterly||22 Jul 2015||14 Oct 2015||10 Nov 2015||USD||—||7c|
|Paid||Quarterly||27 Apr 2015||15 Jul 2015||10 Aug 2015||USD||—||7c|
|Paid||Quarterly||23 Jan 2015||15 Apr 2015||11 May 2015||USD||—||7c|
|Paid||Quarterly||23 Oct 2014||14 Jan 2015||06 Feb 2015||USD||—||7c|
|Paid||Quarterly||24 Jul 2014||15 Oct 2014||07 Nov 2014||USD||—||7c|
|Paid||Quarterly||22 Apr 2014||16 Jul 2014||08 Aug 2014||USD||—||7c|
|Paid||Quarterly||24 Jan 2014||15 Apr 2014||09 May 2014||USD||—||7c|
|Paid||Quarterly||24 Oct 2013||15 Jan 2014||07 Feb 2014||USD||—||7c|
|Paid||Quarterly||26 Jul 2013||16 Oct 2013||08 Nov 2013||USD||—||7c|
|Paid||Quarterly||13 Jun 2013||17 Jul 2013||09 Aug 2013||USD||—||7c|
|Paid||Quarterly||25 Jan 2013||17 Apr 2013||10 May 2013||USD||—||7c|
|Paid||Quarterly||24 Oct 2012||16 Jan 2013||08 Feb 2013||USD||—||7c|
|Paid||Quarterly||–||17 Oct 2012||09 Nov 2012||USD||—||7c|
|Paid||Quarterly||–||18 Jul 2012||10 Aug 2012||USD||—||7c|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Perkinelmer, Inc. Optimized Dividend Chart
About Perkinelmer, Inc.
PerkinElmer, Inc., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics.
Discovery & Analytical Solutions
The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. For the environmental market, it develops and provides analytical technologies, solutions and services that enable its customers to understand the characterization and health of many aspects of environment, including air, water and soil. The Company's technologies are used to detect and help reduce the impact products and industrial processes may have on the environment. For food market, it provides various solutions that help farmers and food producers provide a growing population with food that is safe and nutritious. The Company's instruments are also used to detect the presence of potentially dangerous contaminants, such as lead and mercury in milk. Its solutions can also be used to identify the origin of food products such as olive oil, which helps prevent counterfeiting. Its methods and analyses are transferable throughout the supply chain so its customers are able to keep pace with industry standards as well as governmental regulations and certifications.
The Company provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. The Company's industrial instrumentation is used by customers focusing on quality assurance standards. In the life science research market, it provides a suite of solutions including reagents, informatics, and detection and imaging technologies that enable scientists to increase life science research and facilitate the drug discovery processes. These products, solutions and services support pharmaceutical and biotech companies, and academic institutions. The Company's research portfolio includes a range of systems consisting of imaging, detection and extraction instrumentation for use on in vitro, ex vivo, and in vivo models, analysis hardware and software, plus a range of consumable products, including drug discovery and research reagents. The Company provides services designed to enable its customers in the laboratory services market throughout the world. The Company's OneSource laboratory service business is aligned with customers' needs to accelerate science by enabling gains within their labs.
The Company's principal products and services for Discovery & Analytical Solutions applications in the environmental, food and industrial markets include Clarus series of gas chromatographs, gas chromatographs/mass spectrometers; the TurboMatrix family of sample-handling equipment are used to identify and quantify compounds in the environmental, forensics, food and beverage, hydrocarbon processing/biofuels, materials testing, pharmaceutical and semiconductor industries; Altus UPLC and high performance liquid chromatography (HPLC) advanced liquid chromatography systems providing high throughput and resolution chromatographic separations; AxION 2 TOF MS that is designed to simplify and streamline virtually any analytical workflow and provides mass accuracy, full spectrum capability, speed, sensitivity, and dynamic range; AxION Direct Sample Analysis (DSA), which is a sample introduction system that enables direct sample analysis with minimal sample preparation and no chromatography; Torion T-9 portable GC/MS, a person-portable gas chromatography/ mass spectrometry (GC/MS) system, enabling rapid detection and actionable results to potentially hazardous and emergency environmental conditions; atomic spectroscopy family of instruments, including the AAnalyst/PinAAcle series of atomic absorption spectrometers, the Avio/Optima family of inductively coupled plasma (ICP) optical emission spectrometers and the NexION family of ICP mass spectrometers are used in the environmental and chemical industries, among others, to determine the elemental content of a sample; LAMBDA UV/Vis, a series of spectrophotometers that provide sampling flexibility to enable measuring of a range of sample types, including liquids, powders and solid materials, both in regulated industries as well as quality control/quality assurance (QC/QA) and research applications; 2400 Series II CHNS/O Elemental Analyzer, an organic elemental analyzer, and Perten's Falling Number and Glutomatic instruments that determine the bread baking quality of wheat and flour. It also includes products, such as Avio 200, which is the smallest inductively coupled plasma-optical emission spectroscopy (ICP-OES) on the market, offering the lowest argon consumption of any ICP; QSight Triple Quad LC/MS/MS, which is a flow-based mass spectrometry system that provides high sensitivity; Delta range of milk quality analyzers that ensure the quality of dairy products and are used at Central Milk Testing labs as well as dairy processing facilities around the world, and Bioo Scientific test kits for detection of toxins, veterinary drug residues and contaminants enable testing at various steps in the food value chain.
The Company's principal products and services for Discovery & Analytical Solutions applications in the life sciences research and laboratory services include Phenoptics quantitative pathology research solutions that provide oncologists and cancer immunologists a new way to visualize and measure tumor cells and multiple immune-cell phenotypes simultaneously in FFPE tissue by combining the power of Opal multiplexed immunohistochemistry reagents with the Mantra or Vectra 3 Multispectral Imaging System, enabling visualization and analysis of complex cell interactions in ways that are difficult to achieve with other methods; radiometric detection solutions, including over 1,100 radiochemicals NEN and the Tri-carb, Quantulus GCT families of liquid scintillation analyzers, Wizard2 Gamma counters and MicroBeta2 plate based LSA that are used for beta, gamma and luminescence counting in microplate and vial formats utilized in research, environmental and drug discovery applications; Opera Phenix high content screening system, which is used for sensitive and high speed phenotypic drug screening of complex cellular models; Operetta CLS high content analysis system; Columbus image data storage and analysis system; EnSight multimode plate reader benchtop system that offers well plate imaging alongside label-free and labeled detection technologies for target-based and phenotypic assays; EnVision multilabel plate reader that is targeted towards a range of high-throughput screening applications, including those using AlphaScreen, AlphaLISA and/or AlphaPlex technologies, and G4 PET/X-ray and G8 PET/CT preclinical imaging systems. It also includes products, such as Alpha SureFire Ultra Multiplex Assays that are used for the rapid, sensitive and quantitative detection of phosphoproteins in cells, combined with the measurement of the total amount of the same protein in a single well; CellCarrier Ultra 384-well microplates that are used in high content imaging applications such as phenotypic screening and three-dimensional disease model studies, and PerkinElmer Signals for Translational, a cloud-based data management, aggregation and analysis platform, which integrates experimental and clinical research data from many sources and relates the data to scientifically meaningful concepts in life sciences research market.
The Company offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help increase the health of families. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. For the diagnostics market, the Diagnostics segment provides early detection for genetic disorders from pregnancy to early childhood, as well as infectious disease testing. Its screening products are designed to provide early insights into the health of expectant mothers during pregnancy and into the health of their babies. Its instruments, reagents and software test and screen for genetic abnormalities, disorders and diseases, including Down syndrome, hypothyroidism, infertility and various metabolic conditions. It also develops the technologies that enable and support sample-to-sequencer workflow using next-generation deoxyribose nucleic acid (DNA) sequencing for applications in oncology, genetic testing and drug discovery.
The Company's principal products and services for Diagnostics applications in the diagnostics market include DELFIA Xpress screening platform, a complete solution for prenatal and maternal health screening, which includes a continuous loading system; NeoBase Non-derivatized MS/MS kit analyzes newborn blood samples for measurement of amino acids and other metabolic analytes for specific diseases; Specimen Gate informatics data management solution, which is designed specifically for newborn screening laboratories; ViaCord umbilical cord blood banking services for the banking of stem cells harvested from umbilical cord blood and cord tissue, for potential therapeutic application in transplant and regenerative medicine; Next-Generation Sequencing (NGS) Library Prep and multiplexing kits; and EnLite Neonatal TREC System, a screening test for Severe Combined Immunodeficiency, consisting of EnLite Neonatal TREC reagent kits, the Victor EnLite instrument and EnLite Workstation software. Its products and services in applied genomics include Automated liquid handling platforms (JANUS, Sciclone and Zephyr) that offer a choice of robotic solutions in genomics, biotherapeutics, high throughput screening and high content analysis to assist life science research from bench to clinic; LabChip GXII Touch that provides a means of characterizing multiple protein product attributes for research labs through QC, and cell::explorer automated workstation that allows integration of multiple laboratory instrumentation using a centralized robotic interface, allowing high throughput and turnkey-application focused solutions.
- Technology Hardware & Equipment
- United States
- Share Price
- $148.52 (yesterday's closing price)
- Shares in Issue
- 111 million
- Market Cap
- Market Indices
- S&P 500